|
|
||||||||
REVIEW |
1 Office of Chemical Safety (MDP 88), Therapeutic Goods Administration, Department of Health and Ageing, PO Box 100, Woden ACT 2606, Australia
2 Department of Medical Biochemistry, School of Medicine, Faculty of Health Sciences, Flinders University, GPO Box 2100, Adelaide, South Australia 5001, Australia
(Requests for offprints should be addressed to G Barritt; Email: greg.barritt{at}flinders.edu.au)
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Although there is evidence that TRPM8 is involved in thermo and pain sensation in sensory neurons, the knowledge of the functions of TRPM8 in other cell types, including prostate cancer cells, is very limited. The detection of TRPM8 in a number of normal urogenital tissues and the profile of up-regulated expression of TRPM8 in prostate cancer and other cancer cells suggest that this Ca2+-permeable channel may play diverse roles in different tissues.
| Structure of TRPM8 |
|---|
|
|
|---|
|
| Activation signals and mechanisms for TRPM8 |
|---|
|
|
|---|
|
Another agent that plays an important role in the activation of TRPM8 is phosphatidylinositol 4,5-bisphosphate (PIP2). Liu & Qin (2005) showed that the inactivation (desensitisation) of the TRPM8 channel is prevented by inhibitors of phospholipid phosphatases. Moreover, the application of exogenous PIP2 was found to both activate the channel directly and to restore activity after desensitisation (Liu & Qin 2005). Using a slightly different experimental strategy, Rohacs et al. (2005) provided evidence that PIP2 is necessary for the activation of TRPM8 by cold or cooling agents. Moreover, PIP2 itself (in the absence of cold or a cooling agent) could also activate the channel. Cold or a cooling agent increases the apparent affinity of TRPM8 for PIP2 and it is proposed that cooling activates the channel by increasing the sensitivity to PIP2. Evidence has been obtained to indicate that PIP2 binds to positive changes in the TRP motif in the cytoplasmic carboxy terminus (shown schematically in Fig. 1
). As pointed out by Rohacs et al. (2005), the activation mechanisms of TRPM8 are undoubtedly complex. It is likely that the role of PIP2 is part of, or linked to, the effects of cold and cooling agents in changing the activation energy of the channel (Voets et al. 2004). Confirmation of these ideas will require further experiments.
Ca2+ plays an important role in regulating the activity of TRPM8. Recent studies by Chuang et al. (2004) have shown that the activation of TRPM8 by icilin requires an increase in the cytoplasmic Ca2+ concentration ([Ca2+]cyt) at the cytoplasmic mouth of the channel i.e. the flow of Ca2+ through the channel (Fig. 1
). They suggested that this requirement for Ca2+ might represent the coincidence detection of signals by TRPM8 (Chuang et al. 2004). These authors also provided evidence that indicates that the region of the TRPM8 polypeptide that appears to interact with icilin is similar in structure to the region of hot-sensing TRPV1 that interacts with capsaicin.
Ca2+ inflow also plays a role in modulating (desensitising) TRPM8. Thus it has been found that Ca2+ inflow through TRPM8 activates phospholipase C (PLC) (possibly PLC
1) which hydrolyses PIP2, leading to a decrease in PIP2 and inhibition (desensitisation) of channel activity (Fig. 1
) (Rohacs et al. 2005). This may be one of numerous examples (for many types of Ca2+ permeable channel) of the physiological importance of limiting the amount of Ca2+ which enters the cell via the open channel, and hence the necessity of there being effective mechanisms for achieving this.
Several research groups have compared the properties of the cold-sensing TRPM8 channels with those of the hot-sensing TRPV channels. It was found that TRPM8 is inhibited by 2-aminoethoxydiphenyl borate (2-APB) (Hu et al. 2004). 2-APB inhibits several types of plasma membrane Ca2+-permeable channels and, under some conditions, it also inhibits inositol 1,4,5-trisphosphate receptors (Bootman et al. 2002). 2-APB can be used to distinguish TRPM8 from TRPV1, V2 and V3, since it activates TRPV1, V2 and V3 but inhibits TRPM8 (Hu et al. 2004). These observations most likely reflect differences in either the pores of the channels or in the activation mechanisms.
Other similarities and differences between TRPM8 and TRPV1 have been described by Weil et al. (2005) using the whole cell patch-clamp technique to study channel function. They showed that TRPM8 activity is modified by ethanol, TRPM8 is not affected by extracellular H+ whereas TRPV1 does respond to extracellular H+, and many of the TRPV1 antagonists, including capsazepine, BCTC, (2R)-4-(3-chloro-2 pyridinyl)-2-methyl-N-[4-(trifluoromethyl)phenyl]-1 piperazonecarboxamide (CTPC) and SB-452533, are also antagonists of TRPM8. These results have implications for both the structure and mechanism of activation of TRPM8, and also highlight potential difficulties in developing pharmaceutical interventions selective for TRPM8.
| Expression and functions of TRPM8 in neuronal cells |
|---|
|
|
|---|
|
| Expression of TRPM8 in prostate cancer cells |
|---|
|
|
|---|
|
In malignant tissue specimens from patients with a total serum PSA concentration in the grey-zone of 410 ng/ml, TRPM8 mRNA, but not PSA mRNA was significantly elevated. Thus the detection of TRPM8 expression could be useful in the differential diagnosis of prostate cancer in biopsy specimens to facilitate therapeutic decisions particularly in ambiguous cases often found in this total PSA grey-zone. More interestingly, in identified groups of low- and high-grade prostate cancer, significant differences in expression between malignant and non-malignant tissue samples were found for TRPM8 but not for other prostate cancer markers, including PSA. It was concluded that, compared with the other markers (PSA, hK2 and PSCA), TRPM8 is a more specific indicator of prostate cancer and a potential candidate for targetted gene therapy or other interventions (Fuessel et al. 2003). However, as discussed below, expression of TRPM8 in prostate cancer cells is closely linked to the presence of a functional androgen receptor. Bidaux et al. (2005) have drawn attention to the complexities caused by this link and hence in using TRPM8 as a prognostic marker for prostate cancer.
A significant proportion of TRPM8 is observed in the plasma membrane of prostate cancer cells, although the protein has also been observed in intracellular membranes (Zhang & Barritt 2004). Extracellular domains of the protein can potentially activate cytotoxic T-lymphocytes. One such region, the GLMKYIGEV, has been identified (Kiessling et al. 2003). This may provide an endogenous mechanism that enhances the destruction of prostate cancer cells expressing TRPM8 part of the normal immunological defence mechanisms. Loss of TRPM8 expression in metastatic prostate cancer cells may, therefore, be associated with a reduction in prostate cancer cell destruction. On the other hand, the activation of cytotoxic T-lymphocytes by the GLMKYIGEV region may offer the possibility of an immunotherapeutic approach to killing prostate cancer cells based on this or another TRPM8 peptide as target (Kiessling et al. 2003).
| Regulation of TRPM8 by androgens in prostate cancer cells |
|---|
|
|
|---|
The question of what mechanism underlies the androgen regulation of TRPM8 in androgen-responsive prostate cancer cells has been addressed, and several putative androgen response elements have been detected (Zhang & Barritt 2004, Bidaux et al. 2005). Analysis of 5' flank regions of the TRPM8 gene using GenoMatix reveals that a region which spans 1500 bp upstream of the transcription initiation code in the TRPM8 gene may be the core promoter for TRPM8 DNA transcription. This promoter region contains a variety of putative transcriptional factor binding sites including at least three TATA boxes, a transcription factor Sp1, a transcript enhancer factor Tef, three NKX3.1 binding sites and an androgen-responsive element (Table 2
, Fig. 4
). The last mentioned exhibits a high degree of homology to a motif corresponding to the TRANSFAC androgen-responsive element consensus sequence (c.f. Zhang & Barritt 2004, Bidaux et al. 2005). Further analysis reveals another nine putative androgen-responsive elements in the introns of the TRPM8 gene (Fig. 4
), and two in the 3' untranslated region. It is possible that in androgen-responsive prostate cancer cells (which have functional androgen receptors) the androgenandrogen receptor complex binds with androgen response elements in either the promoter region or introns in the TRPM8 gene. Together with other transcription co-factors, this may initiate TRPM8 gene transcription.
|
|
| Physiological functions of TRPM8 in prostate cancer cells |
|---|
|
|
|---|
It has been proposed that, in LNCaP cells, an increased growth rate correlates with an increase in the amount of Ca2+ in intracellular stores, whereas a decreased rate of growth correlates with a reduced load of Ca2+ in intracellular stores (Legrand et al. 2001). TRPM8 may, with other ER-located Ca2+ pool regulators (e.g. ER (Ca2++Mg2+)ATPase), modulate the amount of Ca2+ in intracellular stores and subsequently regulate cell growth and proliferation (Fig. 5A
).
|
A more detailed study of the tissue and intracellular locations of the TRPM8 protein in the prostate has shown that TRPM8 is principally expressed in prostate epithelial cells (Bidaux et al. 2005). A low level of TRPM8 expression was also found in smooth muscle cells. In prostate epithelial cells, the highest level of TRPM8 expression was seen in the apical region of secretory epithelial cells, with much lower amounts of TRPM8 found in the basal regions. Expression of TRPM8 in secretory epithelial cells of the prostate decreased with time as the cells were grown in primary culture and became dedifferentiated. Bidaux et al. (2005) have suggested that TRPM8 is involved in the secretory function of prostate epithelial cells. Secretory products include citric acid, fibrinolysin, acid phosphatase, several other enzymes and lipids. Noting the androgen-dependence of TRPM8 expression and a role for androgens in oocyte fertilisation, these authors have suggested that one of the functions of androgen-regulated TRPM8 is in fertilisation.
In addition to normal prostate epithelium, TRPM8 is also detected in a number of urogenital tissues including testis, seminiferous tubules, scrotal skin, and bladder urothelium (Tsukimi et al. 2005) (Table 1
). This systemic expression profile implies that TRPM8 may have yet to be identified roles associated with reproduction and/or sexuality.
On the basis of the observation that TRPM8 expression is upregulated in organ-confined prostate cancer cells and in a number of other cancerous cell types, TRPM8 could function as an oncogene. TRPM8 may contribute to the initiation, promotion and progression of carcinogenesis by disturbing Ca2+ homeostasis in preAneoplastic cells. It has been reported that early pre-neoplastic cells are highly susceptible to apoptosis, whereas later pre-neoplastic cells are quite resistant (Preston et al. 1997). Moreover, increases in [Ca2+]cyt and intra-organelle Ca2+ play key roles in apoptosis (Mattson & Chan 2003). Although several hypotheses have been proposed to explain the resistance of cells (such as androgen-unresponsive prostate cancer cells) to apoptosis, a plausible mechanism involving Ca2+ signalling has been presented (reviewed in Prevarskaya et al. 2004) in which reduced Ca2+ levels in the ER were observed in early pre-neoplastic cells that undergo apoptosis compared with a higher level of stored Ca2+ in the ER in late pre-neoplastic cells. Over-expressed or upregulated TRPM8 channels could cause an increase in [Ca2+]cyt and an overfilling of ER Ca2+ store and this change in Ca2+ homeostasis would make the late pre-neoplastic cells more resistant to apoptotic stimuli and subsequently promote cell transformation into a neoplastic stage.
In addition, the detection of putative binding sites for tumour suppressor protein p53, prostate-specific homeodomain protein NKX3.1, and zinc-finger binding protein-89 (ZBP-89; Merchant et al. 2003) (Table 2
) in the TRPM8 gene promoter region implies that TRPM8 may serve as a downstream target of tumour-suppressor genes. (ZBP-89 is a butyrate-regulated co-activator of p53, and is able to induce p21(Waf1) gene expression through both p53-dependent and -independent mechanisms to inhibit cell growth (Merchant et al. 2003).) Thus TRPM8 may be involved in the regulation of cell growth and carcinogenesis. Taken together, the above results suggest that TRPM8 is a novel prostate cancer bio-marker, is likely to play an important role in the pathophysiology of prostate epithelial cells, and is a potential target for the action of drugs in the treatment of prostate cancer.
| The consequences of sustained activation of TRPM8 induced by pharmacological intervention in prostate cancer cells |
|---|
|
|
|---|
| Conclusions |
|---|
|
|
|---|
TRPM8 is potentially a valuable diagnostic tissue marker and prognostic indicator for the progress of prostate cancer. Additional knowledge, which might establish this role for TRPM8 could include measurement of TRPM8 expression at the protein (as well as the mRNA) level. Further studies are needed to compare TRPM8 expression with other established prostate cancer markers in terms of accuracy and probability. The limitation of using TRPM8 as a marker is that prostate tissues are needed for the examination of TRPM8 levels. The regulation of TRPM8 expression by androgens is important in terms of both fundamental knowledge and understanding the role of TRPM8 in prostate cancer. Further experiments might be directed at identifying androgen response elements and perhaps other hormone response elements in the promoter and intron regions, and at understanding the mechanisms underlying up-regulation of TRPM8 in cancerous tissues. Finally, TRPM8 may be a potential target for pharmaceutical or genetic interventions for the treatment of prostate cancer and other cancers with over-expression of TRPM8. Further experiments might include screening for the specific and potent agonists for activation of the TRPM8 channel and exploring the strategy in vivo.
| Acknowledgements |
|---|
| References |
|---|
|
|
|---|
Andersson DA, Chase HW & Bevan S 2004 TRPM8 activation by menthol, icilin, and cold is differentially modulated by intracellular pH. Journal of Neuroscience 24 53645369.
Babes A, Zorzon D & Reid G 2004 Two populations of cold-sensitive neurons in rat dorsal root ganglia and their modulation by nerve growth factor. European Journal of Neuroscience 20 22762282.[CrossRef][Web of Science][Medline]
Behrendt HJ, Germann T, Gillen C, Hatt H & Jostock R 2004 Characterization of the mouse cold-menthol receptor TRPM8 and vanilloid receptor type-1 VR1 using a fluorometric imaging plate reader (FLIPR) assay. British Journal of Pharmacology 141 737745.[CrossRef][Web of Science][Medline]
Bidaux G, Roudbaraki M, Merle C, Crépin A, Delcourt P, Slomianny C, Thebault S, Bonnal J-L, Benahmed M, Cabon F et al. 2005 Evidence for specific TRPM8 expression in human prostate secretory epithelial cells: functional androgen receptor requirement. Endocrine-Related Cancer 12 367382.
Bootman MD, Collins TJ, Mackenzie L, Roderick HL, Berridge MJ & Peppiatt CM 2002 2-Aminoethoxy-diphenyl borate (2-APB) is a reliable blocker of store-operated Ca2+ entry but an inconsistent inhibitor of InsP3-induced Ca2+ release. FASEB Journal 16 11451150.
Brauchi S, Orio P & Latorre R 2004 Clues to understanding cold sensation: thermodynamics and electrophysiological analysis of the cold receptor TRPM8. PNAS 101 1549415499.
Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI & Isaacs WB 1990 Allelic loss of chromosomes 16q and 10q in human prostate cancer. PNAS 87 87518755.
Chuang HH, Neuhausser WM & Julius D 2004 The supercooling agent icilin reveals a mechanism of coincidence detection by a temperature-sensitive TRP channel. Neuron 43 859869.[CrossRef][Web of Science][Medline]
Clapham DE 2003 TRP channels as cellular sensors. Nature 426 517524.[CrossRef][Medline]
Culig Z, Klocker H, Eberle J, Kaspar F, Hobisch A, Cronauer MV & Bartsch G 1993 DNA sequence of the androgen receptor in prostatic tumour cell lines and tissue specimens assessed by means of the polymerase chain reaction. Prostate 22 1122.[Web of Science][Medline]
Fuessel S, Sickert D, Meye A, Klenk U, Schmidt U, Schmitz M, Rost AK, Weigle B, Kiessling A & Wirth MP 2003 Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR. International Journal of Oncology 23 221228.[Web of Science][Medline]
He WW, Sciavolino PJ, Wing J, Augustus M, Hudson P, Meissner PS, Curtis RT, Shell BK, Bostwick DG, Tindall DJ et al. 1997 A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. Genomics 43 6977.[CrossRef][Web of Science][Medline]
Henshall SM, Afar DE, Hiller J, Horvath LG, Quinn DI, Rasiah KK, Gish K, Willhite D, Kench JG, Gardiner-Garden M et al. 2003 Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse. Cancer Research 63 41964203.
Hu HZ, Gu Q, Wang C, Colton CK, Tang J, Kinoshita-Kawada M, Lee LY, Wood JD & Zhu MX 2004 2-Aminoethoxydiphenyl borate is a common activator of TRPV1, TRPV2 and TRPV3. Journal of Biological Chemistry 279 3574135748.
Hui K, Guo Y & Feng Z-P 2005 Biophysical properties of menthol-activated cold receptor TRPM8 channels. Biochemical and Biophysical Research Communications 333 374382.[CrossRef][Medline]
Kiessling A, Füssel S, Schmitz M, Stevanovic S, Meye A, Weigle B, Klenk U, Wirth MP & Rieber EP 2003 Identification of an HLA-A *0201-restricted T-cell epitope derived from the prostate cancer-associated protein trp-p8. Prostate 56 270279.[CrossRef][Web of Science][Medline]
Legrand G, Humez S, Slomianny C, Dewailly E, Vanden Abeele F, Mariot P, Wuytack F & Prevarskaya N 2001 Ca2+ pools and cell growth. Evidence for sarcoendoplasmic Ca2+-ATPases 2B involvement in human prostate cancer cell growth control. Journal of Biological Chemistry 276 4760847614.
Liu B & Qin F 2005 Functional control of cold- and menthol-sensitive TRPM8 ion channels by phosphatidylinositol 4,5-bisphosphate. Journal of Neuroscience 25 16741678.
Lundgren R, Kristoffersson U, Heim S, Mandahl N & Mitelman F 1988 Multiple structural chromosome rearrangements, including del(7q) and del(10q), in an adenocarcinoma of the prostate. Cancer Genetics and Cytogenetics 35 103108.[CrossRef][Web of Science][Medline]
McKemy DD 2005 How cold is it? TRPM8 and TRPA1 in the molecular logic of cold sensation. Molecular Pain 1 16.[Medline]
McKemy DD, Neuhausser WM & Julius D 2002 Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 416 5258.[CrossRef][Medline]
Mattson MP & Chan SL 2003 Calcium orchestrates apoptosis. Nature Cell Biology 5 10411043.[CrossRef][Web of Science][Medline]
Merchant JL, Bai L & Okada M 2003 ZBP-89 mediates butyrate regulations of gene expression. Journal of Nutrition 133 2456S2460S.
Montell C 2005 The TRP superfamily of cation channels. Sciences Signal Transduction Knowledge Environment 272 ref 3.
Moreno O, Chen F, Duncan D, Graddis T, Laus R, McDole K, Morkowski S, Natarajan G & Wang C 2005 Modulation of the Trp-p8 ion channel for the treatment of cancer. 96th American Association for Cancer Research Annual Meeting, April 1620. Session ID (Poster): Experimental and Molecular Therapeutics 21 Identification of Molecular Targets 2. PNAS 46 2372.
Nealen ML, Gold MS, Thut PD & Caterina MJ 2003 TRPM8 mRNA is expressed in a subset of cold-responsive trigeminal neurons from rat. Journal of Neurophysiology 90 515520.
Nilius B, Talavera K, Owsianik G, Prenen J, Droogmans G & Voets T 2005 Gating of TRP channels: a voltage connection? Journal of Physiology 567 3544.
Okazawa M, Inoue W, Hori A, Hosokawa H, Matsumura K & Kobayashi S 2004 Noxious heat receptors present in cold-sensory cells in rats. Neuroscience Letters 359 3336.[CrossRef][Web of Science][Medline]
Paubert-Braquet M, Cousse H, Raynaud JP, Mencia-Huerta JM & Braquet P 1998 Effect of the lipidosterolic extract of Serenoa repens (Permixon) and its major components on basic fibroblast growth factor-induced proliferation of cultures of human prostate biopsies. European Urology 33 340347.[CrossRef][Medline]
Peier AM, Moqrich A, Hergarden AC, Reeve AJ, Andersson DA, Story GM, Earley TJ, Dragoni I, McIntyre P, Bevan S et al. 2002 A TRP channel that senses cold stimuli and menthol. Cell 108 705715.[CrossRef][Web of Science][Medline]
de la Pena E, Malkia A, Cabedo H, Belmonte C & Viana F 2005 The contribution of TRPM8 channels to cold sensing in mammalian neurones. Journal of Physiology 567 415426.
Phillips SM, Morton DG, Lee SJ, Wallace DM & Neoptolemos JP 1994 Loss of heterozygosity of the retinoblastoma and adenomatous polyposis susceptibility gene loci and in chromosomes 10p, 10q and 16q in human prostate cancer. British Journal of Urology 73 390395.[Web of Science][Medline]
Prescott JL, Blok L & Tindall DJ 1998 Isolation and androgen regulation of the human homeobox cDNA, NKX3.1. Prostate 35 7180.[CrossRef][Web of Science][Medline]
Preston GA, Barrett JC, Biermann JA & Murphy E 1997 Effects of alterations in calcium homeostasis on apoptosis during neoplastic progression. Cancer Research 57 537542.
Prevarskaya N, Skryma R & Shuba Y 2004 Ca2+ homeostasis in apoptotic resistance of prostate cancer cells. Biochemical and Biophysical Research Communications 322 13261335.[CrossRef][Medline]
Rohacs T, Lopes CMB, Michailidis I & Logothetis DE 2005 PI(4,5)P2 regulates the activation and desensitization of TRPM8 channels through the TRP domain. Nature Neuroscience 8 626634.[CrossRef][Web of Science][Medline]
Russin WA, Hoesly JD, Elson CE, Tanner MA & Gould MN 1989 Inhibition of rat mammary carcinogenesis by monoterpenoids. Carcinogenesis 10 21612164.
Stein RJ, Santos S, Nagatomi J, Hayashi Y, Minnery BS, Xavier M, Patel AS, Nelson JB, Futrell WJ, Yoshimura N et al. 2004 Cool (TRPM8) and hot (TRPV1) receptors in the bladder and male genital tract. Journal of Urology 172 11751178.[CrossRef][Web of Science][Medline]
Story GM, Peier AM, Reeve AJ, Eid SR, Mosbacher J, Hricik TR, Earley TJ, Hergarden AC, Andersson DA, Hwang SW et al. 2003 ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 112 819829.[CrossRef][Web of Science][Medline]
Thut PD, Wrigley D & Gold MS 2003 Cold transduction in rat trigeminal ganglia neurons in vitro. Neuroscience 119 10711083.
Tominaga M & Caterina MJ 2004 Thermosensation and pain. Journal of Neurobiology 61 312.[CrossRef][Web of Science][Medline]
Tsavaler L, Shapero MH, Morkowski S & Laus R 2001 Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. Cancer Research 61 37603769.
Tsukimi Y, Mizuyachi K, Yamasaki Y, Niki T & Hayashi F 2005 Cold response of the bladder in guinea pig: involvement of transient receptor potential channel, TRPM8. Urology 65 406410.[CrossRef][Web of Science][Medline]
Voeller HJ, Augustus M, Madlike V, Bova GS, Carter KC & Gelmann EP 1997 Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers. Cancer Research 57 44554459.
Voet D & Voet JG 1990 Biochemistry. New York: John Wiley & Sons.
Voets T, Droogmans G, Wissenbach U, Janssens A, Flockerzi V & Nilius B 2004 The principle of temperature-dependent gating in cold- and heat-sensitive TRP channels. Nature 430 748754.[CrossRef][Medline]
Weil A, Moore SE, Waite NJ, Randall A & Gunthorpe MJ 2005 Conservation of functional and pharmacological properties in the distantly related temperature sensors TRPV1 and TRPM8. Molecular Pharmacology 68 518527.
Zhang L & Barritt GJ 2004 Evidence that TRPM8 is an androgen-dependent Ca2+ channel required for the survival of prostate cancer cells. Cancer Research 64 83658373.
Zhang L, Jones S, Brody K, Costa M & Brookes SJ 2004 Thermosensitive transient receptor potential channels in vagal afferent neurons of the mouse. American Journal of Physiology. Gastrointestinal Liver Physiology 286 G983G991.
This article has been cited by other articles:
![]() |
A. S. Sabnis, M. Shadid, G. S. Yost, and C. A. Reilly Human Lung Epithelial Cells Express a Functional Cold-Sensing TRPM8 Variant Am. J. Respir. Cell Mol. Biol., October 1, 2008; 39(4): 466 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Sabnis, C. A. Reilly, J. M. Veranth, and G. S. Yost Increased transcription of cytokine genes in human lung epithelial cells through activation of a TRPM8 variant by cold temperatures Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L194 - L200. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Malkia, R. Madrid, V. Meseguer, E. de la Pena, M. Valero, C. Belmonte, and F. Viana Bidirectional shifts of TRPM8 channel gating by temperature and chemical agents modulate the cold sensitivity of mammalian thermoreceptors J. Physiol., May 15, 2007; 581(1): 155 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kiselyov, A. Soyombo, and S. Muallem TRPpathies J. Physiol., February 1, 2007; 578(3): 641 - 653. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Nilius, G. Owsianik, T. Voets, and J. A. Peters Transient Receptor Potential Cation Channels in Disease Physiol Rev, January 1, 2007; 87(1): 165 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Gudermann and S. Roelle Calcium-dependent growth regulation of small cell lung cancer cells by neuropeptides Endocr. Relat. Cancer, December 1, 2006; 13(4): 1069 - 1084. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |